Cohort study of non-alcoholic fatty liver disease, nafld fibrosis score, and the risk of incident diabetes in a korean population

American Journal of Gastroenterology

Volumn 108, Issue 12, 2013, Pages 1861-1868

  Chang, Yoosoo ^a,b   Jung, Hyun Suk ^b   Yun, Kyung Eun ^b   Cho, Juhee ^b,c   Cho, Yong Kyun ^b   Ryu, Seungho ^a,b  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Sungkyunkwan University   (South Korea)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; HEMOGLOBIN A1C; HIGH SENSITIVITY C REACTIVE PROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; AGE DISTRIBUTION; ALCOHOL CONSUMPTION; ARTICLE; BLOOD PRESSURE; BODY MASS; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DIET RESTRICTION; DISEASE ASSOCIATION; DISEASE SEVERITY; ECHOGRAPHY; EXERCISE; FAMILY HISTORY; FASTING SERUM GLUCOSE; FATTY LIVER; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; HOMEOSTASIS MODEL ASSESSMENT OF INSULIN RESISTANCE; HUMAN; HYPERTENSION; INCIDENCE; INSULIN RESISTANCE; KOREA; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NON ALCOHOLIC FATTY LIVER DISEASE FIBROSIS SCORE; NONALCOHOLIC FATTY LIVER; OBESITY; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCORING SYSTEM; SENSITIVITY ANALYSIS; SMOKING;

ADULT; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; FATTY LIVER; FEMALE; HUMANS; INCIDENCE; LIVER CIRRHOSIS; MALE; MIDDLE AGED; REPUBLIC OF KOREA; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 84889658153     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2013.349     Document Type: Article

References (48)

1. Lazo M, Clark JM. The epidemiology of nonalcoholic fatty liver disease: A global perspective. Semin Liver Dis 2008; 28 : 339-50.
2. Ascha MS, Hanouneh IA, Lopez R et al. The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis. Hepatology 2010; 51 : 1972-8.
3. Marchesini G, Marzocchi R, Agostini F et al. Nonalcoholic fatty liver disease and the metabolic syndrome. Curr Opin Lipidol 2005; 16 : 421-7.
4. Utzschneider KM, Kahn SE. Review: The role of insulin resistance in nonalcoholic fatty liver disease. J Clin Endocrinol Metab 2006; 91 : 4753-61.
5. Ryan MC, Wilson AM, Slavin J et al. Associations between liver histology and severity of the metabolic syndrome in subjects with nonalcoholic fatty liver disease. Diabetes Care 2005; 28 : 1222-4.
6. Marchesini G, Bugianesi E, Forlani G et al. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology 2003; 37 : 917-23.
7. Angulo P, Hui JM, Marchesini G et al. The NAFLD fibrosis score: A noninvasive system that identifi es liver fibrosis in patients with NAFLD. Hepatology 2007; 45 : 846-54.
8. Angulo P, Keach JC, Batts KP et al. Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis. Hepatology 1999; 30 : 1356-62.
9. Loomba R, Abraham M, Unalp A et al. Association between diabetes, family history of diabetes, and risk of nonalcoholic steatohepatitis and fibrosis. Hepatology 2012; 56 : 943-51.
10. Kimura Y, Hyogo H, Ishitobi T et al. Postprandial insulin secretion pattern is associated with histological severity in non-alcoholic fatty liver disease patients without prior known diabetes mellitus. J Gastroenterol Hepatol 2011; 26 : 517-22.
11. Shibata M, Kihara Y, Taguchi M et al. Nonalcoholic fatty liver disease is a risk factor for type 2 diabetes in middle-aged Japanese men. Diabetes Care 2007; 30 : 2940-4.
12. Yamada T, Fukatsu M, Suzuki S et al. Fatty liver predicts impaired fasting glucose and type 2 diabetes mellitus in Japanese undergoing a health checkup. J Gastroenterol Hepatol 2010; 25 : 352-6.
13. Bae JC, Rhee EJ, Lee WY et al.combined effect of nonalcoholic fatty liver disease and impaired fasting glucose on the development of type 2 diabetes: A 4-year retrospective longitudinal study. Diabetes Care 2011; 34 : 727-9.
14. Kim CH, Park JY, Lee KU et al. Fatty liver is an independent risk factor for the development of Type 2 diabetes in Korean adults. Diabet Med 2008; 25 : 476-81.
15. Fan JG, Li F, Cai XB et al. effects of nonalcoholic fatty liver disease on the development of metabolic disorders. J Gastroenterol Hepatol 2007; 22 : 1086-91.
16. Targher G, Byrne CD. Nonalcoholic fatty liver disease: A novel cardiometabolic risk factor for type 2 diabetes and its complications. J Clin Endocrinol Metab 2013; 98 : 483-95.
17. Park SK, Seo MH, Shin HC et al. Clinical availability of nonalcoholic fatty liver disease as an early predictor of type 2 diabetes mellitus in Korean men: 5-year prospective cohort study. Hepatology 2013; 57 : 1378-83.
18. Saadeh S, Younossi ZM, Remer EM et al. The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology 2002; 123 : 745-50.
19. Sass DA, Chang P, Chopra KB. Nonalcoholic fatty liver disease: A clinical review. Dig Dis Sci 2005; 50 : 171-80.
20. Angulo P. Long-term mortality in nonalcoholic fatty liver disease: Is liver histology of any prognostic signifi cance Hepatology 2010; 51 : 373-5.
21. Musso G, Gambino R, Cassader M et al. Meta-analysis: Natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of noninvasive tests for liver disease severity. Ann Med 2011; 43 : 617-49.
22. Gronbaek H, Th omsen KL, Rungby J et al. Role of nonalcoholic fatty liver disease in the development of insulin resistance and diabetes. Expert Rev Gastroenterol Hepatol 2008; 2 : 705-11.
23. Chang Y, Ryu S, Sung E et al. Higher concentrations of alanine aminotransferase within the reference interval predict nonalcoholic fatty liver disease. Clin Chem 2007; 53 : 686-92.
24. Chang Y, Ryu S, Sung E et al. Weight gain within the normal weight range predicts ultrasonographically detected fatty liver in healthy Korean men. Gut 2009; 58 : 1419-25.
25. Kim CW, Yun KE, Jung HS et al. Sleep duration and quality in relation to non-alcoholic fatty liver disease in middle-aged workers and their spouses. J Hepatol 2013; 59 : 351-7.
26. Chalasani N, Younossi Z, Lavine JE et al. The diagnosis and management of non-alcoholic fatty liver disease: Practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology 2012; 55 : 2005-23.
27. Mathiesen UL, Franzen LE, Aselius H et al. Increased liver echogenicity at ultrasound examination reflects degree of steatosis but not of fibrosis in asymptomatic patients with mild/moderate abnormalities of liver transaminases . Dig Liver Dis 2002; 34 : 516-22.
28. Kim CW, Yun KE, Jung HS et al. Sleep duration and quality in relation to non-alcoholic fatty liver disease in middle-aged workers and their spouses. J Hepatol 2013; 59 : 351-7.
29. Wen CP, David Cheng TY, Tsai SP et al. Are Asians at greater mortality risks for being overweight than Caucasians Redefi ning obesity for Asians. Public Health Nutr 2009; 12 : 497-506.
30. Ryu S, Chang Y, Kim SG et al. Serum uric acid levels predict incident nonalcoholic fatty liver disease in healthy Korean men. Metabolism 2011; 60 : 860-6.
31. Matthews DR, Hosker JP, Rudenski AS et al. Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28 : 412-9.
32. Vallet-Pichard A, Mallet V, Nalpas B et al. FIB-4: An inexpensive and accurate marker of fibrosis in HCV infection.comparison with liver biopsy and fibrotest. Hepatology 2007; 46 : 32-6.
33. Shah AG, Lydecker A, Murray K et al.comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol 2009; 7 : 1104-12.
34. Wai CT, Greenson JK, Fontana RJ et al. A simple noninvasive index can predict both signifi cant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 2003; 38 : 518-26.
35. Cales P, Laine F, Boursier J et al.comparison of blood tests for liver fibrosis specifi c or not to NAFLD. J Hepatol 2009; 50 : 165-73.
36. Biddinger SB, Kahn CR. From mice to men: Insights into the insulin resistance syndromes. Annu Rev Physiol 2006; 68 : 123-58.
37. Lattuada G, Ragogna F, Perseghin G. Why does NAFLD predict type 2 diabetes Curr Diab Rep 2011; 11 : 167-72.
38. Dowman JK, Tomlinson JW, Newsome PN. Pathogenesis of non-alcoholic fatty liver disease. QJM 2010; 103 : 71-83.
39. Qatanani M, Lazar MA. Mechanisms of obesity-associated insulin resistance: Many choices on the menu. Genes Dev 2007; 21 : 1443-55.
40. Liu Q, Bengmark S, Qu S. The role of hepatic fat accumulation in pathogenesis of non-alcoholic fatty liver disease (NAFLD). Lipids Health Dis 2010; 9 : 42.
41. Unger RH. Lipid overload and overflow: Metabolic trauma and the metabolic syndrome. Trends Endocrinol Metab 2003; 14 : 398-403.
42. Seppala-Lindroos A, Vehkavaara S, Hakkinen AM et al. Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men. J Clin Endocrinol Metab 2002; 87 : 3023-8.
43. Samuel VT, Liu ZX, Qu X et al. Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease. J Biol Chem 2004; 279 : 32345-53.
44. Hernaez R, Lazo M, Bonekamp S et al. Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: A meta-analysis. Hepatology 2011; 54 : 1082-90.
45. Ryan CK, Johnson LA, Germin BI et al. One hundred consecutive hepatic biopsies in the workup of living donors for right lobe liver transplantation. Liver Transpl 2002; 8 : 1114-22.
46. Diagnosis and classifi cation of diabetes mellitus. Diabetes Care 2010; 33 (Suppl 1) : S62-9.
47. Bonora E, Tuomilehto J. The pros and cons of diagnosing diabetes with A1C. Diabetes Care 2011; 34 (Suppl 2) : S184-90.
48. Cowie CC, Rust KF, Ford ES et al. Full accounting of diabetes and prediabetes in theus population in 1988-1994 and 2005-2006. Diabetes Care 2009; 32 : 287-94.